Please provide your email address to receive an email when new articles are posted on . The IC-OS definition of immune checkpoint inhibitor-associated myocarditis demonstrated good diagnostic ...

AMSTERDAM -- Anti-inflammatory immunosuppressant anakinra (Kineret) held no survival benefit for acute myocarditis, the randomized phase IIb ARAMIS trial showed. The interleukin-1 receptor antagonist ...

Stanford scientists may be closing in on an explanation for a rare cardiac side effect experienced by a small number of people a few days after they received a COVID-19 shot. Fewer than 30 people in ...

Individuals who develop myocarditis after receiving the mRNA-based COVID-19 vaccine from Pfizer/BioNTech fare much better than those who develop the condition for other reasons, affirm data from Hong ...

Despite being younger and having fewer comorbidities, patients with acute myocarditis (AM) had a significantly higher risk for 30-day and long-term mortality than those with unexplained chest pain.

Researchers in Portugal successfully treated a case of acute myocarditis in a patient with monkeypox and say it should be on physicians’ radars as a rare, but potentially serious complication. Online ...

Amsterdam, Netherlands – 28 Aug 2023: The largest randomised controlled trial of patients with acute myocarditis has found that anakinra is safe but does not reduce complications. The late breaking ...

An examination of data of people who received the Pfizer-BioNTech COVID-19 vaccine in Israel found males 14 to 30 years of age were the most susceptible to myocarditis after a second or third dose of ...